Documented FDA 524B SBOM Consultants, NTIA-Compliant, CI/CD-Generated
You are searching for an FDA 524B SBOM consultant because the SBOM is the deliverable reviewers machine-check first: format validity, minimum-element completeness, and consistency with the threat model are all scriptable rejection reasons.
The firms below are verified on SBOM practice that survives review, CycloneDX 1.5+ or SPDX 2.3+ machine-readable output, automated regeneration in CI/CD, and known-vulnerability assessment workflows that tie the SBOM to the postmarket plan.
What renders on this page
- ▸Matrix of firms with NTIA minimum-element compliance tags
- ▸SBOM format checkmarks (CycloneDX 1.5+, SPDX 2.3+) and CI/CD generation flags
- ▸Direct "Request Secure RFP" form pre-wired to the FDA 524B template
The SBOM that passes is the one that stays current
A hand-assembled SBOM is accurate until the next build. Firms verified here implement SBOM generation inside the build pipeline, so the artifact submitted matches the artifact shipped, and the postmarket plan can consume updates without re-authoring.
Known-vulnerability assessment is part of the deliverable
Section 524B(b) requires a plan to address exploited vulnerabilities postmarket. The SBOM is only useful if it feeds that monitoring, verified firms show KEV/NVD triage workflows connected to device risk decisions, not just a bill of materials.
What fda 524b sbom consultant engagements typically cost, and what drives the price
No honest page quotes a single number, because the price of fda 524b sbom consultant work varies by scope. The drivers that move quotes are the number of devices and device families in scope, and whether the work is premarket (submission support) or postmarket (monitoring and patching), the maturity of your existing documentation, a draft SBOM and threat model cost less to review than to build from zero, and the stage of your FDA submission calendar, work compressed against a submission deadline is priced differently from work scheduled ahead of it. For real numbers, use the verified directory's rate data and from structured RFP responses with real quotes from device-security consultancies.
How long it takes
Premarket cybersecurity documentation typically runs alongside your regulatory timeline, not after it, SBOM and threat-model work starts with design inputs.
Penetration testing is bounded by test-unit availability and lab scheduling, not by the firm's calendar alone.
Postmarket vulnerability management is continuous by definition, the first engagement sets the monitoring rhythm.
What to prepare before you engage a firm
The firms you are about to compare will scope faster (and quote more accurately) if you arrive with your intended-use statement and device architecture documentation, a software bill of materials (SBOM), or a statement of where you stand on building one, any existing threat model or risk assessment artifacts, even drafts, and the regulatory pathway you are pursuing (510(k), De Novo, PMA) and where you are in it.
Common mistakes to avoid when choosing
treating cybersecurity documentation as a late submission-stage checkbox rather than a design-input activity
commissioning a penetration test before the threat model exists, testing against an unranked attack surface wastes budget
buying SBOM tooling without the engineering process to keep the SBOM current, an SBOM that goes stale at submission helps no one
What happens after you engage
A well-run fda 524b sbom consultant engagement follows a predictable arc: a gap assessment against FDA's premarket and postmarket cybersecurity guidance (and Section 524B requirements where they apply), then a documentation work plan sequenced against your submission calendar, then the technical work (threat modeling, testing, SBOM remediation) with evidence in the format reviewers expect, and finally submission support: reviewer-question responses and postmarket handoff. If a firm cannot describe this arc for your environment, that itself is a finding.
Frequently asked questions
CycloneDX or SPDX for an FDA submission?
Both are FDA-recognized. CycloneDX is more common in medical device CI/CD toolchains; SPDX has broader enterprise governance adoption. Verified firms list which they generate natively versus via conversion, conversion loses element fidelity.
What does SBOM remediation cost for an existing device?
Retrofitting SBOM generation onto a legacy device line typically runs low-to-mid five figures per product family depending on build-system archaeology. New development integrates at a fraction of that. The RFP captures product-line count and build maturity.
How much does medical device cybersecurity consulting cost?
Cost tracks device-family count, documentation maturity, and your submission stage, the three drivers above. The verified directory lists device-security consultancies with disclosed rate data where available, and structured RFP responses return real quotes for your specific device scope.
When in the device lifecycle should we engage a security firm?
Before the threat model is due as a design input, not at submission. Firms engaged early can shape the SBOM and threat-model work into the design process; firms engaged late can only document what already happened.